SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 614.23 |
| Enterprise Value ($M) | 464.09 |
| Book Value ($M) | 196.86 |
| Book Value / Share | 2.77 |
| Price / Book | 3.12 |
| NCAV ($M) | 181.50 |
| NCAV / Share | 2.55 |
| Price / NCAV | 3.38 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.34 |
| Return on Assets (ROA) | 0.37 |
| Return on Equity (ROE) | 0.42 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.23 |
| Current Ratio | 4.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 238.99 |
| Assets | 254.35 |
| Liabilities | 57.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 139.92 |
| Operating Income | 83.62 |
| Net Income | 68.07 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 94.80 |
| Cash from Investing | -0.02 |
| Cash from Financing | -43.42 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Lewis John Latane IV |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 42,617 | 191,730 | 22.23 | |
| 35,664 | 179,747 | 19.84 | |
| 32,882 | 167,806 | 19.60 | |
| 90,490 | 311,712 | 29.03 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SAGE – Sage Therapeutics, Inc. | SCYX – SCYNEXIS, Inc. |
| SGMT – Sagimet Biosciences Inc. | SKYE – Skye Bioscience, Inc. |
| SLGL – Sol-Gel Technologies Ltd. |
Financial data and stock pages provided by
Fintel.io